["Cluster"-headache (Bing-Horton syndrome?)].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000367:Age Factors; D003348:Cortisone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004569:Electroencephalography; D004878:Ergotamine / Q000627:therapeutic use; D006261:Headache / Q000175:diagnosis; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000175:diagnosis; D010640:Phenothiazines / Q000627:therapeutic use; D010918:Pizotyline / Q000627:therapeutic use; D012737:Sex Factors; D013557:Switzerland; D013997:Time Factors; D014653:Vascular Headaches / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology
D010640:Phenothiazines; D010918:Pizotyline; D000324:Adrenocorticotropic Hormone; D004878:Ergotamine; D003348:Cortisone; D008784:Methysergide
"Cluster"-Kopfschmerz (Bing-Horton-Syndrom)